TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 34,163 | 27,503 | 28,285 |
Financial expenses | 234 | 392 | 355 |
Earnings before taxes | -8,059 | -11,938 | -8,433 |
EBITDA | 235 | -3,266 | 111 |
Total assets | 90,880 | 99,277 | 118,059 |
Current assets | 42,982 | 49,304 | 60,701 |
Current liabilities | 14,966 | 13,186 | 11,923 |
Equity capital | 70,341 | 80,898 | 99,733 |
- share capital | 3,492 | 3,601 | 3,658 |
Employees (average) | 22 | 24 | 22 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 77.4% | 81.5% | 84.5% |
Turnover per employee | 1,553 | 1,146 | 1,286 |
Profit as a percentage of turnover | -23.6% | -43.4% | -29.8% |
Return on assets (ROA) | -8.6% | -11.6% | -6.8% |
Current ratio | 287.2% | 373.9% | 509.1% |
Return on equity (ROE) | -11.5% | -14.8% | -8.5% |
Change turnover | 7,486 | 1,172 | -9,538 |
Change turnover % | 28% | 4% | -25% |
Chg. No. of employees | -2 | 2 | 1 |
Chg. No. of employees % | -8% | 9% | 5% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.